The American Society of Health System Pharmacists is accepting applications for its 2017 ASHP Executive Residency in Association Leadership and Management. Read More »

Naloxone has been made available without the need for a prescription in all Walgreens pharmacy locations in the Louisiana. Read More »

Amgen will partner with Janssen Biotech to assess the drug combination made up of KYPROLIS, developed by Amgen, and DARZALEX, developed by Janssen, over the course of multiple clinical trials for the treatment of patients who have multiple myeloma. Read More »

Cigna is asking medical groups to join the effort of decreasing opioid use by 25 percent by signing a pledge to reduce opioid prescriptions and treat opioid abuse as a chronic condition. Read More »

The American Pharmacists Association recently released a video that commemorates its Pharmacy-based Immunization Certificate Training Program’s 20th anniversary. Read More »

A new report by the Surgeon General has discovered that alcohol and drug misuse and severe substance addiction is one of the nation’s crucial health concerns. Read More »

Centers for Disease Control and Prevention President and CEO Dr. Judith Monroe has received the 2016 NACDS Foundation Excellence in Patient Care Award. Read More »

According a new research study conducted by Visante, pharmacy benefit managers are saving consumers and payers $941 on average per person a year. Read More »

Rite Aid's Black Friday deals continue through the weekend. Read More »

RxGenomix's training program in Pharmacogenomics has been approved by the American Pharmacists Association as a continuing pharmacy education credit. Read More »

Baxter International recently presented data regarding the SHARESOURCE remote patient management platform and the AMIA automated peritoneal dialysis system and their roles in more efficient home dialysis while supporting patients and their ability to be independent. Read More »

Neovacs will partner with 3P Biopharmaceuticals to manufacture interferon alpha following its purchase of technology from AMEGABIOTECH. Read More »

Eli Lilly and Co.'s EXPEDITION3 clinical study involving solanezumab failed to meet its primary goal in treating Alzheimer’s. Read More »

Baxter International recently presented its research on extracorporeal blood purification and its role in the removing of molecules associated with inflammation at the American Society of Nephrology’s annual Kidney Week. Read More »

Novo Nordisk's Changing Diabetes in Children program has received a four-year extension to provide access to diabetes care and free insulin to children in developing countries who have Type 1 diabetes. Read More »

Merck has released new data involving KEYTRUDA, Merck’s anti-PD-1 therapy designed for the treatment of a number of blood cancers, and its investigational use. Read More »

Mallinckrodt's Phase 2 clinical study involving H.P. Acthar Gel to evaluate the effectiveness of the medication on patients who have Amytropic Lateral Sclerosis will begin in 2017. Read More »

CVS Pharmacy's Black Friday sales event will give its ExtraCare members the opportunity to save. Read More »

Arrowhead Pharmaceuticals has closed the license and collaboration agreement with Amgen regarding the RNAi ARC-LPA program. Read More »

Intarcia Therapeutics has submitted its New Drug Application (NDA) for ITCA 650 to the U.S. Food and Drug Administration. Read More »